Developmental Core

发展核心

基本信息

  • 批准号:
    10593147
  • 负责人:
  • 金额:
    $ 28.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-16 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

ABSTRACT – JHU TRAC DEVELOPMENTAL CORE (DC) The mission of the Developmental Core (DC) is to support and mentor the next generation of TB researchers and to recruit new TB investigators to increase the diversity and breadth of TB scientists at Johns Hopkins University (JHU). Early Stage Investigators (ESI) need to integrate a variety of disciplines into their work, and innovative leaders in other fields need to be brought into the TB research fold to generate transformational gains in basic and clinical research, translation, and implementation. Despite the productivity and accomplishments of the JHU faculty, nurturing and sustaining a pipeline of New Investigators (NI) who can provide leadership and innovation in the future is extremely challenging. Without dedicated resources to support NI and ESI, many trainees move onto other fields. There is a recognized need for seed funding, core resources, and intensive mentoring for new researchers, who also would benefit from broadened skill sets beyond their primary training. The DC will seek to draw from areas of underrepresented science and scientists, including opportunities for future research/training. Fields such as systems biology in TB are lacking; thus, we will seek to bring in computational modelers, bioinformaticians, and immunologists to fill this void. Novel approaches to understanding TB pathogenesis are needed, with implications for molecular diagnostics, therapeutic vaccines, and host-directed therapies. Nursing models to increase prevention, access to treatment, retention and human- centered adherence models, as well as infection control and prevention science are recognized areas needing TB outsiders. Finally, engagement of stakeholders in community-based participatory research methods is increasingly needed in TB control globally. The overall goals of the JHU TRAC DC are to support the highest priority innovative, cross-disciplinary TB research, to support and mentor ESI in team science, and to recruit and support NI to TB. Developmental Awards provided by the DC will provide both ESI and established investigators not currently involved in TB research with the opportunity to stimulate innovative ideas and to receive support for fruitful new areas of interdisciplinary, collaborative research. A special focus of the DC will be the recruitment and career development of Investigators among groups nationally underrepresented in health-related research (UHRR). In addition to the Developmental Awards, the Developmental Core will augment individual mentorship with Internal Scientific Reviews of grant proposals, including specific aims reviews; TRAC-specific Writing Accountability Groups (WAGs), a TRAC K- Club to support development of K01, K08, K23, or K99 applications, and a TRAC K2R Club for investigators transitioning from K awards to R01 grants. The Developmental Core will work with the Administrative Core to facilitate exchange of ideas and methodologies through a weekly TRAC Seminar Series, research-in-progress meetings, workshops, and the annual JHU TB Scientific Meeting and TRAC Data Fair.
摘要 – JHU TRAC 发展核心 (DC) 发展核心 (DC) 的使命是支持和指导下一代结核病研究人员 并招募新的结核病研究人员,以增加约翰·霍普金斯大学结核病科学家的多样性和广度 大学(JHU)。早期研究者 (ESI) 需要将各种学科融入到他们的工作中,并且 需要将其他领域的创新领导者纳入结核病研究领域,以产生变革性收益 从事基础和临床研究、翻译和实施。尽管生产力和成就 约翰霍普金斯大学 (JHU) 的教职人员,培养和维持一批新研究者 (NI),他们可以提供领导力和 未来的创新极具挑战性。如果没有专门的资源来支持 NI 和 ESI,许多 受训者转向其他领域。人们公认需要种子资金、核心资源和集约化资源 为新研究人员提供指导,他们也将从初级培训之外的更广泛的技能中受益。 DC 将寻求从代表性不足的科学和科学家领域汲取经验,包括为 未来的研究/培训。结核病系统生物学等领域缺乏;因此,我们将努力引入 计算建模师、生物信息学家和免疫学家来填补这一空白。新颖的方法 需要了解结核病的发病机制,这对分子诊断、治疗性疫苗、 和宿主导向疗法。加强预防、获得治疗、保留和人力的护理模式 以中心为中心的依从模型以及感染控制和预防科学是公认需要的领域 结核病外人。最后,利益相关者参与基于社区的参与性研究方法是 全球结核病控制的需求日益增加。 JHU TRAC DC 的总体目标是支持最优先的创新、跨学科结核病 研究,支持和指导 ESI 团队科学,并招募和支持 NI 参与 TB 工作。发展奖 由 DC 提供的信息将为 ESI 和目前未参与结核病研究的既定研究者提供 有机会激发创新想法并获得跨学科新领域的支持, 合作研究。 DC 的一个特别重点将是调查员的招聘和职业发展 全国范围内健康相关研究 (UHRR) 代表性不足的群体。除了发育方面 奖项、发展核心将通过拨款的内部科学审查来加强个人指导 提案,包括具体目标审查; TRAC 特定写作责任小组 (WAG),一个 TRAC K- 支持 K01、K08、K23 或 K99 应用程序开发的俱乐部,以及供研究人员使用的 TRAC K2R 俱乐部 从 K 奖过渡到 R01 补助金。发展核心将与行政核心合作 通过每周举行的 TRAC 研讨会系列、正在进行的研究促进思想和方法的交流 会议、研讨会以及年度 JHU TB 科学会议和 TRAC 数据博览会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONATHAN E. GOLUB其他文献

JONATHAN E. GOLUB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONATHAN E. GOLUB', 18)}}的其他基金

TB PuRe : Pulmonary rehabilitation to reduce post-tuberculosis morbidity
TB PuRe :肺康复可降低结核病后发病率
  • 批准号:
    10586385
  • 财政年份:
    2023
  • 资助金额:
    $ 28.78万
  • 项目类别:
Developmental Core
发展核心
  • 批准号:
    10431022
  • 财政年份:
    2022
  • 资助金额:
    $ 28.78万
  • 项目类别:
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.
评估南非艾滋病毒感染者戒烟干预措施:功效、实施和成本效益。
  • 批准号:
    10269650
  • 财政年份:
    2021
  • 资助金额:
    $ 28.78万
  • 项目类别:
TB Aftermath
结核病后果
  • 批准号:
    9895147
  • 财政年份:
    2020
  • 资助金额:
    $ 28.78万
  • 项目类别:
TB Aftermath
结核病后果
  • 批准号:
    10171763
  • 财政年份:
    2020
  • 资助金额:
    $ 28.78万
  • 项目类别:
TB Aftermath
结核病后果
  • 批准号:
    10431874
  • 财政年份:
    2020
  • 资助金额:
    $ 28.78万
  • 项目类别:
PREVINE-TB: PRevent: EValuating the implementation of NEw strategies for preventive TB among people living with HIV in Brazil
PREVINE-TB:预防:评估巴西艾滋病毒感染者预防结核病新战略的实施情况
  • 批准号:
    10179305
  • 财政年份:
    2018
  • 资助金额:
    $ 28.78万
  • 项目类别:
PREVINE-TB: PRevent: EValuating the implementation of NEw strategies for preventive TB among people living with HIV in Brazil
PREVINE-TB:预防:评估巴西艾滋病毒感染者预防结核病新战略的实施情况
  • 批准号:
    10426171
  • 财政年份:
    2018
  • 资助金额:
    $ 28.78万
  • 项目类别:
Quantiferon Gold Test for Detecting TB Infection in HIV/AIDS Patients in Brazil
用于检测巴西艾滋病毒/艾滋病患者结核感染的 Quantiferon Gold 检测
  • 批准号:
    8843075
  • 财政年份:
    2013
  • 资助金额:
    $ 28.78万
  • 项目类别:
The Impact of Diabetes on TB treatment outcomes
糖尿病对结核病治疗结果的影响
  • 批准号:
    8607116
  • 财政年份:
    2013
  • 资助金额:
    $ 28.78万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 28.78万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 28.78万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 28.78万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 28.78万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 28.78万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 28.78万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 28.78万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 28.78万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 28.78万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 28.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了